2397 — DNA Chip Research Income Statement
0.000.00%
Last trade - 00:00- ¥5bn
- ¥4bn
- ¥490m
Annual income statement for DNA Chip Research, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 362 | 325 | 428 | 328 | 490 |
| Cost of Revenue | |||||
| Gross Profit | 89.7 | 66.2 | 89.2 | -35.6 | 66.4 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 485 | 493 | 589 | 686 | 749 |
| Operating Profit | -123 | -169 | -161 | -358 | -259 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -128 | -172 | -133 | -361 | -246 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -128 | -172 | -134 | -362 | -248 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -128 | -172 | -134 | -362 | -248 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -128 | -172 | -134 | -362 | -248 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -25.2 | -30.8 | -23.8 | -62.3 | -39 |
| Dividends per Share |